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Abstract
Background: The epidemic sizes of influenza A/H3N2, A/H1N1, and B infections vary from year to year in the United States.
We use publicly available US Centers for Disease Control (CDC) influenza surveillance data between 1997 and 2009 to study
the temporal dynamics of influenza over this period.
Methods and Findings: Regional outpatient surveillance data on influenza-like illness (ILI) and virologic surveillance data
were combined to define a weekly proxy for the incidence of each strain in the United States. All strains exhibited a negative
association between their cumulative incidence proxy (CIP) for the whole season (from calendar week 40 of each year to
calendar week 20 of the next year) and the CIP of the other two strains (the complementary CIP) from the start of the season
up to calendar week 2 (or 3, 4, or 5) of the next year. We introduce a method to predict a particular strain’s CIP for the whole
season by following the incidence of each strain from the start of the season until either the CIP of the chosen strain or its
complementary CIP exceed certain thresholds. The method yielded accurate predictions, which generally occurred within a
few weeks of the peak of incidence of the chosen strain, sometimes after that peak. For the largest seasons in the data,
which were dominated by A/H3N2, prediction of A/H3N2 incidence always occurred at least several weeks in advance of the
peak.
Conclusion: Early circulation of one influenza strain is associated with a reduced total incidence of the other strains,
consistent with the presence of interference between subtypes. Routine ILI and virologic surveillance data can be combined
using this new method to predict the relative size of each influenza strain’s epidemic by following the change in incidence
of a given strain in the context of the incidence of cocirculating strains.
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Influenza epidemics in temperate latitudes are usually charac-
terized by the dominance of influenza B or one of two influenza A
subtypes, A/H3N2 and A/H1N1. There are currently no formal
methods to predict which type or subtype (henceforth referred to
in this article as ‘‘strain’’) will dominate in a given season or what
the epidemic size of each strain might be. This paper examines
how routine surveillance data collected during the course of an
influenza season can be used to make predictions for that season.
We also investigate whether there is support for the hypothesis that
the dynamics of different strains are interdependent, and
specifically whether high incidence of one strain interferes with
the circulation of other strains within a season.
Previous epidemiological studies have suggested that subtypes of
influenza A, and potentially influenza A and influenza B, might
compete with each other. Sonoguchi and colleagues [1] studied
the impact of the same-season circulation of A/H3N2 and A/
H1N1 influenza in Japanese schools and concluded that infection
with A/H3N2 was negatively associated with subsequent infection
with A/H1N1. Cowling et al. [2] have found that those infected
with seasonal influenza A during the 2008–2009 season in Hong
Kong had a lower risk of laboratory-confirmed pandemic A/
H1N1 infection. Ferguson et al. [3] and Tria et al. [4] concluded
that strong, transient, nonspecific immunity effective against all
influenza strains was necessary to produce realistic patterns of
sequence diversity in simulations of influenza A and B evolution.
Cobey and colleagues (personal communication) found evidence of
cross-immunity between influenza A/H3N2, A/H1N1, and B in
St. Petersburg, Russia. Skowronski et al. [5] found that people
vaccinated against seasonal influenza in 2008–2009 were more
likely to get infected in the subsequent wave of A/pandemic
(H1N1) 2009 (H1N1pdm) compared to individuals who have not
received seasonal influenza vaccination, an effect that may have
been caused in part by reduced risk of seasonal influenza infection
(owing to receipt of seasonal influenza vaccine), and hence reduced
cross-subtype immunity.
In this study, US Centers for Disease Control (CDC) data
between 1997 and 2009 retrievedfrom a publicly available database
[6]wereexaminedforepidemiologicalevidenceofinteractioninthe
dynamics of the three influenza strains that circulated prior to the
2009 pandemic, A/H3N2, A/H1N1, and B. We utilized two
components of the CDC influenza surveillance system: virologic
surveillance and outpatient ILI surveillance, described in the
Methods and in more detail in [7]. For each season, we defined a
proxy for strain-specific incidence (henceforth simply ‘‘incidence’’)
of each strain and defined the cumulative incidence proxy (CIP) for
any strain at a given time as the sum of its incidence proxy since the
start of the season—see the first section of the Methods for the
precise definition and the discussion of its potential limitations. For
every chosen (index) strain, the ‘‘complementary’’ CIP was defined
as the sum of the CIPs of the other two strains. The index strain’s
CIP for the whole season and the complementary CIP early in the
season were found to be negatively correlated. In particular, for
each index strain, the seasons with the largest early complementary
CIP were also the seasons with the smallest whole-season CIP,
which is a proxy of the strain’s epidemic size. This finding naturally
leads to two questions: First, is there a threshold for the
complementary CIP that predicts a small epidemic for the index
strain? Second, if this complementary CIP threshold isn’t reached,
how does one predict the epidemic size of the index strain? This
paper introduces a method for making these predictions. The
approach is to follow the incidence of each strain from the start of a
season until either the CIPof the index strain or the complementary
CIP surpass certain thresholds that are delineated in this study.
Once the threshold is reached, the CIP of the index strain for the
whole season is predicted in terms of its recent incidence and the
time that the threshold is reached. Historical data [6] were used to
estimate the prediction parameters as well as the accuracy and
timing of predictions.
Figure 1. Weekly incidence proxies of A/H3N2 (green), A/H1N1 (blue), and influenza B (red) strains inferred from [6].
doi:10.1371/journal.pmed.1001051.g001
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Strain-Specific Incidence
Data from [6] for the 12 influenza seasons from 1997–1998 to
2008–2009 were used in the analysis. These data are based on
two components of the CDC influenza surveillance system:
virologic surveillance and outpatient ILI surveillance [7].
Virologic surveillance utilizes data from approximately 80 U.S.
World Health Organization (WHO) Collaborating Laboratories
and 60 National Respiratory and Enteric Virus Surveillance
System (NREVSS) laboratories (which are mostly hospital
laboratories) located throughout the United States. The U.S.
WHO and NREVSS collaborating laboratories report the total
number of respiratory specimens tested and the number positive
for influenza types A and B each week. Most of the U.S. WHO
collaborating laboratories also report the influenza A subtype (H1
or H3) of the viruses they have isolated. For the ILI surveillance
network, each week approximately 1,800 outpatient care sites
around the country report data on the total number of patients
seen and the number of those patients with ILI by age group. For
this system, ILI is defined as fever (temperature of 37.8uCo r
greater) and a cough and/or a sore throat in the absence of a
known cause other than influenza.
Each influenza season was defined as the time between week 40
of one calendar year (epidemiological week 1 in our notation) and
week 20 of the next calendar year (epidemiological week 33). The
emergence of pandemic A/H1N1 in the 2008–2009 season
changed testing and reporting patterns starting in calendar week
17. Therefore, the ending time of the 2008–2009 season was
defined to be calendar week 16 of 2009.
We defined a proxy of weekly strain-specific incidence in the
United States. For each of the ten regions defined by the US
Department of Health and Human Services [6], the proxy for
incidencewasdefined asthe productoftheproportion ofILIamong
all outpatient visits to sentinel physicians and the proportion of
respiratory viral isolates tested that were positive for a particular
Figure 2. The relationship between the cumulative complementary incidence for each of the index strains A/H1N1 (A), A/H3N2 (B),
and B (C) by epidemiological week 16 (calendar week 3) and the index strain’s cumulative incidence over the entire season (i.e., its
epidemic size) for the 12 y in the data.
doi:10.1371/journal.pmed.1001051.g002
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performed. For those samples, the share of A/H1N1 and A/H3N2
was assumed to be proportional to their share among the subtyped
strains. The national proxy for incidence was calculated as the sum
of the regional proxies weighted by the regions’ population sizes.
The size of the regional population for each season between
calendar years X and X+1 was estimated as the mean of the regional
population estimates for July 1 for those years from census data [8].
This proxy would be a perfect measure (up to a multiplicative
constant) of the incidence of infection with a particular strain if the
following conditions were met: (i) the fraction of ILIs that result in
medical consultations, while possibly varying by strain, does not
vary by year or by week; (ii) the numbers of physician visits for all
causes in the sentinel practices were consistent from week to week
during the season; (iii) the sentinel practices were representative of
the full population; and (iv) viral testing, which is conducted in a
separate system, was performed on isolates representative of those
obtained from patients consulting the sentinel practices for ILI. In
reality, none of these assumptions is fully accurate; in particular,
samples are selected for testing on the basis of severity of ILI, as
well as a part of routine sampling. Nonetheless, we take this proxy
measure as the best relative measure of influenza strain-specific
incidence that can be calculated from surveillance data.
Association between the Early Activity of Other Strains
and the Total Activity of Each Strain of Interest
To measure patterns in the observations, for each index strain,
the complementary CIP up to each of several possible calendar
weeks was compared to the CIP of the index strain for the entire
influenza season. We examine the Spearman rank correlation
between those pairs of numbers (i.e., complementary CIP up to a
defined week and the whole season CIP of the index strain) for
each calendar week for the 12 seasons in the data.
If circulation of each strain results in interference with the
others, then such a negative correlation could arise by two
mechanisms. First, high complementary incidence could slow the
spread of the index strain. Second, large seasons of an index strain
may begin early, interfering with the spread of the complementary
strains by the chosen calendar week. We attempt in Text S1 to
disentangle these two mechanisms.
Prediction Model for Cumulative Incidence of a Strain
Given the observed inverse association between the early
complementary CIP and the whole-season CIP of each index
strain (described in the early part of the Results section, below), we
hypothesized that it would be possible to create a prediction
algorithm for the whole-season CIP of each strain. We considered
Figure 3. Predicted versus observed values for influenza A/H1N1 for the choice of thresholds h=140, hc=500.
doi:10.1371/journal.pmed.1001051.g003
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the index strain or the complementary strains reaches a particular
threshold. The week at which this threshold is crossed naturally
varies from season to season, and the thresholds for the index
strain and the complementary strains are allowed to differ. The
first time a threshold is reached, the whole-season CIP of the index
strain is predicted linearly in terms of a proxy X of the index
strain’s recent growth rate as well as the (weighted) time T of
crossing the threshold.
More precisely, one follows the incidence of each strain in time
from the start of a season until either the cumulative incidence of
the index strain in the previous 5 wk surpasses a certain threshold
h or the complementary CIP from the start of a season surpasses a
certain threshold hc (both h and hc vary by index strain as the
different strains have quite different distributions of epidemic
sizes). The time at which one of these conditions is first met is the
‘‘stopping time’’ s. At time s, the whole-season CIP of the index
strain is predicted. Denoting the index strain’s incidence in week w
as I(w), the proxy for recent growth is
X~
I(s)zI(s{1)
max(h,I(s)z:::zI(s{4))
ð1Þ
To elucidate the meaning of the predictor in equation (1), note
that if the index strain’s CIP reaches its threshold, h, first (before
the complementary CIP reaches its threshold, hc) during a period
of positive growth, then X is related to the recent growth rate of
the index strain. If the index strain’s CIP reaches its threshold first
but during a period of no growth or decline, both the covariate X
and index strain’s whole-season CIP, which is the outcome Y, are
expected to be smaller compared to the former scenario. If the
complementary CIP reaches its threshold first, both the covariate
X and the outcome Y are expected to be smaller compared to the
two scenarios above.
For influenza B and A/H1N1, thresholds can be chosen so
that the covariate X is highly correlated with the outcome Y and
the linear regression of Y against X has no outliers (Text S1,
Figure 4. Timing of prediction with regard to weekly influenza A/H1N1 incidence (week 1=calendar week 40). Green lines show the
stopping time s in seasons in which the index strain’s own threshold was crossed first; red lines indicate the stopping times in seasons in which the
complementary threshold was crossed first.
doi:10.1371/journal.pmed.1001051.g004
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season was especially large and early and is an outlier for such
regression. That season was driven by the antigenically novel A/
Fujian-like strain, which presumably had a larger pool of
susceptibles than previous A/H3N2 strains, ensuring an early,
strong season. In particular the threshold for the 2003–2004
season was crossed on calendar week 46—4 wk earlier than in
any other season. The rate of transmission of a strain of
influenza is affected not only by its antigenic novelty but also by
seasonal forcing [9,10]. Correspondingly, the covariate X on
week 46 in 2003, being a function of the incidence’s growth rate
at that time, underestimates the cumulative size of A/H3N2
incidence during that year relative to other years. Similarly, for
the 2010–2011 season, the proxy of influenza B incidence
crossed its threshold exceptionally early compared to the 1997–
2009 seasons, and prediction based on the covariate X alone is
expected to significantly underestimate the whole-season CIP for
influenza B for 2010–2011.
To adjust for the above phenomenon of an early crossing of
the index strain’s threshold h,w et e s t e das e to fm o d e l s
containing an additional predictor T to help explain how the
threshold h relates to a strain’s epidemic size. As described in
Text S1, the best-performing model in this set uses a definition
of T that differs for A/H3N2 versus A/H1N1 and influenza B.
For A/H3N2, T equals the week s in which the threshold is
crossed. For A/H1N1 and influenza B, T equals the week s in
which the threshold is crossed, unless the index strain’s season is
small. The season is defined to be ‘‘small’’ if by week s,t h e
cumulative incidence of the index strain is less than h;i nt h i s
case, the covariate T is set to 0. For each strain, the predictor T
Figure 5. Predicted versus observed values for influenza A/H3N2 for the choice of thresholds h=165, hc=350.
doi:10.1371/journal.pmed.1001051.g005
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that an index strain that crosses its threshold h early in the
season will have a larger epidemic. To understand the
motivation behind this definition of T, we note that for A/
H3N2, seasons in which the complementary threshold is crossed
first are generally associated with later stopping times, and the
week s (=T) of crossing is negatively correlated with the
epidemic size of A/H3N2 (outcome Y). For A/H1N1 and B, a
high complementary CIP early in the season implies that the
complementary threshold was crossed before the CIP threshold
of the index strain, and the timing of such crossing is positively
correlated with the outcome Y. For such seasons, which, in
addition, have ‘‘small’’ CIP of the index strain since the
beginning of the season (as defined above), the covariate T is set
to 0.
With the covariates X and T defined above, the CIP Y is
estimated by
Y~b0zbX:XzbT:T ð2Þ
The coefficients in the linear prediction above were estimated by
ordinary least squares from the historical data in [6]. For influenza
A/H1N1 and B, the intercept b0 was not found to be statistically
significant. This result is not surprising, given that for strong
complementary seasons for those strains, both the outcome and
the covariates are quite small. This intercept was therefore not
used in the linear regression.
A basic measure of the accuracy of the prediction given by
equation (2) is the residual standard error (RSE)
Figure 6. Timing of prediction with regard to weekly influenza A/H3N2 incidence (week 1=calendar week 40). Green lines show the
stopping time s in seasons in which the index strain’s own threshold was crossed first; red lines indicate the stopping times in seasons in which the
complementary threshold was crossed first.
doi:10.1371/journal.pmed.1001051.g006
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ﬃﬃﬃﬃﬃﬃﬃﬃ
1
DF
r
X
(Yi{^ Y Yi)
2 ð3Þ
Here Yi are the observed outcomes, ^ Y Yi are the predicted outcomes
and DF is the number of degrees of freedom. We chose the
thresholds h and hc for each strain by visually inspecting the RSEs
for a wide range of thresholds (Text S1, figure S6) and determining
the space of thresholds where RSE is low and stable.
Sensitivity Analysis
We performed extensive sensitivity analyses on the parameters
used for prediction and the associations between the CIPs of
various strains (Text S1).
Results
Trends in Incidence and the Association between the
Epidemic Size of an Index Strain and the Early
Complementary Cumulative Incidence
The weekly incidence proxies of each strain show clear
differences from season to season (Figure 1). In most seasons, A/
H3N2 has the highest incidence proxy in every week, and B and
A/H1N1 were comparatively scarce. In three seasons, the trend is
partially reversed: A/H1N1 and B are more prevalent than A/
H3N2 in 2000–2001, 2002–2003, and 2008–2009. In 2006–2007,
the incidence of A/H1N1 was distinctly higher than that of A/
H3N2 and B.
There is a negative correlation between the complementary CIP
early in the season and the whole-season CIP of the index strain.
This relation is significant for index strains A/H1N1 and A/H3N2
for each of the calendar weeks 2, 3, 4, and 5; for index strain B,
this relation is significant only for calendar week 2. The relation
between the complementary CIP by calendar week 3 and the
index strain’s whole-season CIP is plotted in Figure 2.
Though the association for influenza B was not statistically
significant the three seasons in which complementary CIP
was highest for B had the three smallest whole-season CIP
for B.
Prediction of the Epidemic Size of Each Strain
This section presents prediction results for a choice of thresholds
for each index strain.
For A/H1N1 the chosen thresholds are h=140, hc=500
(Figures 3 and 4). In the five seasons with appreciable A/H1N1
Figure 7. Predicted versus observed values for influenza B for the choice of thresholds h=80, hc=675.
doi:10.1371/journal.pmed.1001051.g007
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before the peak in two seasons, at the peak in one, and following
the peak in the remaining two.
ForA/H3N2thechosenthresholdsareh=165,hc=350(Figures5
and 6). Prediction occurs before the peak of the A/H3N2 incidence
each season except for the (very small) 2000–2001 season.
For influenza B the chosen thresholds are h=80, hc=675
(Figures 7 and 8). Prediction occurs before the peak of the B
incidence each season.
Table 1 summarizes the estimates and p-values for the
regression coefficients, as well as the RSE for each model.
Discussion
This study demonstrates how routine virologic and ILI
surveillance data can be used to quantify the dynamics of
cocirculating influenza strains and generate short-term predictions
of the relative epidemic sizes of each strain during the course of an
influenza season in the United States. This method should, in
principle, be applicable to other settings/regions provided that the
datasets are large enough for the estimates of the required
quantities (particularly the percent of specimen testing positive for
each strain) to be sufficiently robust.
Regional surveillance data on physician visits for ILI and
subtyping of virologic specimens were combined to define a proxy
for weekly incidence for each of the three strains, A/H3N2, A/
H1N1, and B. This incidence proxy revealed for each index strain
a negative association between the early CIP of the other two
strains (the complementary CIP) and the CIP of the index strain
for the whole season, i.e., the strain’s epidemic size.
The negative association between strains’ incidences suggests
that high infection rates with one strain can interfere with the
transmission of other strains. As noted above, this correlation may
arise from either or both of two mechanisms: early complementary
incidence may slow the spread of the index strain, and early, rapid
spread of the index strain may slow the spread of the
complementary strains. This issue is explored further in Text S1
where we examine the correlation between CIP of various strains
during various time periods. Because A/H3N2 is the only strain
that had large, early epidemics and showed a negative and
significant correlation between its early incidence and the
subsequent incidence of the other strains (Text S1), the data most
strongly support the idea that A/H3N2 incidence interferes with
the circulation of other strains. The negative correlation observed
between a high complementary CIP and the epidemic size of A/
H3N2 has multiple potential interpretations: the pattern is
Figure 8. Timing of prediction with regard to weekly influenza B incidence (week 1=calendar week 40). Green lines show the stopping
time s in seasons in which the index strain’s own threshold was crossed first; red lines indicate the stopping times in seasons in which the
complementary threshold was crossed first.
doi:10.1371/journal.pmed.1001051.g008
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with A/H3N2 and the possibility that weak A/H3N2 seasons
allowed complementary incidence to grow.
The mechanism of short-term heterologous protection may be
also related to a potential impact of vaccination [11]. The
population-level impact of vaccination on the proliferation of
influenza strains not contained in the vaccine is currently unknown.
A Canadian study found that people vaccinated for seasonal
influenza had higher attack rates in the subsequent wave of A/
H1N1pdm [5], an effect that was likely due at least in part to the
lower heterologous protection conferred by the vaccine compared
to natural infection. Vaccination against influenza A/H3N2in mice
prevented the induction of hetero-subtypic immunity against avian
influenza A/H5N1 virus upon subsequent exposure to influenza A/
H3N2 infection [12]. Data in [2] are more ambiguous: higher
infection rates with H1N1 pdm for child recipients of seasonal
influenza vaccine were recorded (32% versus 17%); however, the
statistical significance of this association in the multivariate analysis
depends on the adjustment method. One should note that the
studies above essentially refer to the impact of the activity of
influenzastrains contained inthe vaccine on the activityof influenza
strains not contained in the vaccine, which took place shortly
afterwards. The impact of a vaccine on influenza strains cocirculat-
ing within the same time period is less clear and further
investigations are needed to address this question.
Because seasons with the largest early complementary CIP also
had the smallest epidemics of each index strain, we tested the idea
that one might be able to predict small seasons of an index strain if
the complementary CIP reaches sufficiently high levels in the
course of a season. Alternatively, if the index strain’s incidence
reaches sufficiently high levels first, one might predict the
cumulative size of the index strain’s incidence from its recent
growth rate. We formalize these ideas by introducing thresholds
for the complementary CIP and index CIP; reaching either
threshold triggers a prediction of the whole-season CIP of the
index strain. Because strong seasons of a strain generally start
early, this prediction scheme based on threshold crossing should
allow for a timely identification of a strain’s strong season.
Incidence curves early in the season often have an irregular
shape, which might be due to spatial heterogeneity and other
factors not accounted for by the model. As a result, the threshold
for the index strain’s incidence should be high enough and
sufficiently conservative so that the growth rate will be an accurate
predictor of the epidemic size for that season. Similarly, the
threshold for the complementary CIP is needed to be fairly high,
potentially reflecting significant interference with the index strain.
At the same time, those thresholds shouldn’t be set too high or
they will be reached either very late in the season (when prediction
is of little interest) or never. We expressed the accuracy of the
prediction as a function of the two thresholds by the RSE for the
historical data [6], and we selected the thresholds in the space of
thresholds where the accuracy appeared stable.
Because our model is based on only 12 seasons of observation, it
might overfit the data; at the same time, its performance is
probably affected by the omission of important factors. True
confidence bounds for the prediction should probably be
somewhat wider, as suggested by the ‘‘leave-one-out’’ cross-
validation (Text S1). One potential source of error is the
imperfection of the simple linear model and the predictor
estimated from the incidence data. For example, one often sees
a dent in the growth patterns of the incidence proxies around the
time of winter school closures. If the index strain’s threshold, h,i s
crossed in this period, the growth rate at that point might be
underestimated. In addition, each choice of thresholds essentially
corresponds to a separate model, and we have picked one that
gives a good and stable fit to limited existing data. An important
direction for future research will be to see if similar predictions can
be made by fitting and validating simple models to longer time
series.
The definition of the covariate corresponding to the timing of
threshold crossing is different for influenza A/H3N2 compared to
influenza A/H1N1 and B. The main reason for that difference is
that A/H3N2experienced strong and early seasons in the data. The
exceptionally strong and early 2003–2004 season is the only season
that has a p-value below 0.05 in the leave-one-out cross-validation.
However, incorporating this season into the prediction framework
should give a better adjustment for the timing of threshold crossing,
which in turn should be useful for future predictions of early and
strong influenza A/H3N2 seasons. For influenza A/H1N1 and B,
calibration of the prediction framework based on the 1997–2009
data might not yield accurate predictions of the sizes of
exceptionally strong and early seasons for the index strain. The
ongoing, 2010–2011 season contains an early threshold crossing for
influenzaB compared tothe 1997–2009seasons;moreover,theCIP
ofinfluenzaB bycalendarweek 10of2011 isalreadylargerthan the
whole-season CIP of influenza B in any season in the 1997–2009
data. We expect that recalibration of the prediction framework after
the current season should give a better adjustment for the timing of
threshold crossing for influenza B.
Our method for prediction has several additional limitations
that might affect its applicability since the apparent replacement of
seasonal A/H1N1 by A/H1N1pdm. The quality of the composite
proxy for true influenza infection incidence is uncertain. If the
case-reporting rate of A/H1N1pdm differs from the previous
seasonal A/H1N1, the predictors might require recalculation.
Moreover, the ratio between this indicator and the number of true
(serologic) infections may vary by year for each strain. It is
unknown how the strength of cross-immunity between the strains
Table 1. Predictions of the epidemic sizes of A/H1N1 for the
thresholds.
Predictions Coefficient Coefficient Coefficient RSE
A/H1N1predictions
a
Quantity bX bW RSE
Estimate 1,031.65 29.13 12.02
Standard error 45.8 1.29
p-Value 7?10
210 3?10
25
A/H3N2 predictions
b
Quantity bX bW b0 RSE
Estimate 1,047.35 250.43 965 110.1
Standard error 136.45 10.1 209.7
p-Value 3?10
25 0.0007 0.0013
Influenza B predictions
c
Quantity bX bW RSE
Estimate 622.96 24.13 25.96
Standard error 52.85 1.57
p-Value 3.5?10
27 0.025
ah=140, hc=500.
bPredictions of the epidemic sizes of A/H3N2 for the thresholds h=165,
hc=675.
cPredictions of the epidemic sizes of influenza B for the thresholds h=80,,
,hc=675.
doi:10.1371/journal.pmed.1001051.t001
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consequently unknown how A/H1N1pdm might affect the
strength of these associations. Answering these questions will
require further efforts, including experimental immunological
studies and explicit mechanistic models of transmission dynamics
(e.g., [S. Cobey et al., personal communication]).
Despite its limitations, this method gives a reasonable prediction
of the epidemic sizes of A/H3N2, A/H1N1, and influenza B
relative to historical precedents. In particular, the model predicted
the relative epidemic size of A/H3N2, the strain associated with
the highest rates of mortality [13], on average several weeks before
its peak in seasons in which A/H3N2 dominated. Such predictive
methods may be useful to decision makers when they are trying to
determine in real-time which measures to recommend for an
influenza season.
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Background. Every winter in temperate countries, millions
of people catch influenza, a viral infection of the nose, throat,
and airways. Most infected individuals recover quickly but
seasonal influenza outbreaks (epidemics) kill about half a
million people annually. Epidemics of influenza occur
because small but frequent changes in the viral proteins
(antigens) to which the immune system responds mean that
an immune response produced one year provides only
partial protection against influenza the next year. Annual
immunization with a vaccine that contains killed influenza
viruses of the major circulating strains boosts this natural
immunity and greatly reduces a person’s chances of catching
influenza. Influenza epidemics in temperate latitudes are
usually caused by an influenza B virus or one of two
influenza A subtypes called A/H3N2 and A/H1N1. The names
of the influenza A viruses indicate the types of two major
influenza antigens—hemagglutinin (H3 or H1) and
neuraminidase (N2 or N1)—present in the viruses.
Why Was This Study Done? At present, there is no way to
predict whether influenza B or an influenza A subtype will be
dominant (responsible for the majority of infections) in any
given influenza season. There is also no way to predict the
size of the epidemic that will be caused by each viral strain.
Public health officials would like to be able to make
predictions of this sort early in the winter to help them
determine which measures to recommend to minimize the
illness and death caused by influenza. In this study, the
researchers use weekly influenza surveillance data collected
by the US Centers for Disease Control and Prevention (CDC)
to study the temporal dynamics of seasonal influenza in the
United States between 1997 and 2009 and to develop a
statistical method to predict the sizes of epidemics caused
by influenza A/H1N1, A/H3N2, and B.
What Did the Researchers Do and Find? The CDC
influenza surveillance system collects information on the
proportion of patients attending US outpatient facilities who
have an influenza-like illness (fever and a cough and/or a
sore throat in the absence of any known cause other than
influenza) and on the proportion of respiratory viral isolates
testing positive for specific influenza strains at US viral
surveillance laboratories. The researchers combined these
data to define a weekly ‘‘proxy’’ incidence of each influenza
strain across the United States (an estimate of the number of
new cases per week in the US population) and a cumulative
incidence proxy (CIP) for each influenza season. For each
strain, there was a negative association between its whole-
season CIP and the early-season CIP of the other two strains
(the complementary CIP). That is, high infection rates with
one strain appeared to interfere with the transmission of
other strains. Given this relationship, the researchers then
developed a statistical algorithm (a step-by-step problem
solving method) that accurately predicted the whole-season
CIP for a particular strain by following the incidence of each
strain from the start of the season until either its CIP or the
complementary CIP had exceeded a specific threshold. So,
for example, for influenza B, the algorithm provided an
accurate prediction of the whole-season CIP before the peak
of influenza B incidence for each season included in the
study. Similarly, prediction of whole-season A/H3N2
incidence always occurred several weeks in advance of its
weekly incidence peak.
What Do These Findings Mean? These findings suggest
that early circulation of one influenza strain is associated
with a reduced total incidence of other strains, possibly
because of cross-subtype immunity. Importantly, they also
suggest that routine early-season surveillance data can be
used to predict the relative size of the epidemics caused by
each influenza strain in the United States and in other
countries where sufficient surveillance data are available.
Because the algorithm makes many assumptions and
simplifies the behavior of influenza epidemics, its
predictions may not always be accurate. Moreover, it needs
to be tested with data collected over more influenza seasons.
Nevertheless, the algorithm’s ability to predict the relative
epidemic size of A/H3N2, the influenza strain with the
highest death rates, several weeks before its peak in seasons
in which it was the dominant strain suggests that this
predictive method could help public-health officials
introduce relevant preventative and/or treatment measures
early in each influenza season.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001051.
N The US Centers for Disease Control and Prevention
provides information for patients and health professionals
on all aspects of seasonal influenza, including information
about the US influenza surveillance system
N The UK National Health Service Choices Web site also
provides information for patients about seasonal influenza;
the UK Health Protection Agency provides information on
influenza surveillance in the UK
N MedlinePlus has links to further information about
influenza l (in English and Spanish)
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